Search results
Children with high BMIs should not use obesity medications like WeGovy, US doctors warn
Business Insider· 3 days agoThe US Preventive Services Task Force warned against giving children 6 and older buzzy weight-loss...
Zealand Pharma says weight loss drug could be comparable to GLP1-RAs
Clinical Trials Arena via Yahoo Finance· 1 day agoNovo Nordisk reported DKr61bn in sales from its diabetes and obesity portfolio, accounting for 93.3%...
WHO issues warning about fake weight loss and diabetes drugs
The Independent via Yahoo News· 2 days agoThe WHO issued an alert on false semaglutides, the type of medicines that are used for treatment of...
Bariatric Surgery Lowers CV Risk in People With Sleep Apnea
Medscape· 17 hours agoThis study is important "because it targets the main driver" of OSA, which is obesity and fat accumulation, Ali Aminian, MD, of the Cleveland Clinic, told Medscape Medical ...
New Weight-Loss Drugs and Devices Are Coming This Week
Barrons.com· 4 days agoWeight-loss breakthroughs all emerged from diabetes treatment. Meetings such as the coming American ...
Eli Lilly’s Weight-Loss Franchise Has Been a Massive Winner Under Dave Ricks
Barrons.com· 1 day agoThe company launched Zepbound in December, an anti-obesity competitor to Novo Nordisk Wegovy, and...
England’s child obesity rises 30% since 2006 among 10- and 11-year-olds
South China Morning Post· 2 days agoPotential causes included “shocking levels of poverty and deprivation” and the “aggressive promotion...
England’s Kids Are Getting Shorter Amid Poverty And Poor Nutrition
Forbes· 2 days agoThe average height of England’s 5-year-olds has fallen over the last eleven years, while rates of ...
Type 2 diabetes: How a 5:2 intermittent fasting diet can help
Medical News Today· 2 days agoA study from China suggest that a 5:2 intermittent fasting diet with meal replacement may be helpful...
Tang Prize in Biopharmaceutical Science Honoring Three Scientists
Rome Sentinel· 4 days agoHabener, Svetlana Mojsov, and Jens Juul Holst, for the discovery of GLP-1 (7-37) as an insulinotropic factor and the development of GLP-1 (7-37)-based anti-diabetic and anti-obesity ...